G proteins and endothelium-dependent relaxations

Journal of Vascular Research

Volumn 34, Issue 3, 1997, Pages 175-185

  Boulanger, Chantal M ^a   Vanhoutte, Paul M ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Endothelial dysfunction; Endothelium dependent responses; Gi proteins; Nitric oxide; Regeneration; Serotonin

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; CALCIMYCIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; KETANSERIN; LEUKOTRIENE; MEMBRANE RECEPTOR; METITEPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERTUSSIS TOXIN; PROSTACYCLIN; SEROTONIN; THROMBIN;

BLOOD VESSEL TONE; BLOOD VESSEL WALL; CALCIUM TRANSPORT; CONFERENCE PAPER; ENDOTHELIUM LESION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIUM;

EID: 0030962682     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159221     Document Type: Article

References (101)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980:299:373-376.
2. Furchgott RF: Studies on the relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide: in Vanhoutte PM (ed): Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, New York, Raven Press, 1988, pp 401-414.
3. Liischer TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function, Boca Raton, CRC Press, 1990.
4. Moneada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology, Pharmacol Rev 1991:43:109-142.
5. Cohen RA, Vanhoutte PM: Endothelium-dependent hyperpolarization: Beyond nitric oxide and cyclic GMP, Circulation 1995:92: 3337-3349.
6. Vanhoutte PM: Hypercholestcrolaemia, atherosclerosis and release of endothelium-derived relaxing factors by aggregating platelets, Eur Heart 1991; 12(suppl E):3E-12E.
7. Flavahan N, Vanhoutte PM: G-protcin and endothelial responses, Blood Vessels 1990:27: 218-229.
8. Flavahan N, Vanhoutte PM: Endothelial cell signaling and endothelial dysfunction, Am J Hypertens 1995;8:28S-41S.
9. Basscngc E, Hcusch G: Endothelial and neuro-humoral control of coronary blood low in health and disease, Rev Physiol Biochem Pharmacol 1990:116:79-163.
10. Ignarro LJ, Bvms RE, Wood KS: Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical; in Vanhoutte PM (ed): Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, New York, Raven Press, 1988, pp 427-436.
11. Palmer RMJ, Ferridge AG, Moneada S: Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
12. Rapoport RM, Murad F: Agonist-induced endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP, Circ Res 1983:52:352-357.
13. Palmer RM, Ashton DS, Moneada S: Vascular endothelial cells synthesize nitric oxide from Jarginine. Nature 1988;333:664-666.
14. Lamas S, Marsden PA, Li GK, Tcmpst P, Michel T: Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992:89:20496-20501.
15. Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappcrt KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene, J Biol Chem 1993:268:17478-17488.
16. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmitt HHH, Nahane M, Murad F: Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991:88:10480-10484.
17. Schmidt K, Werner ER, Mayer B, Wächter H, Kukovetz WR: Tetrahydrobiopterin-depcn-dent formation of endothelium-derived relaxing factor (nitric oxide) and aortic endothelial cells. Biochem J 1992;281:297-300.
18. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovine aortic endothelial cell synthase, J Clin Invest 1992;90:2092-2096.
19. Busse R, Mulsch A, Fleming I, Hecker M: Mechanisms of nitric oxide release from the vascular endothelium, Circulation 1993;87: V18-V25.
20. Ayajiki K, Kindermann M, Hecker M, Fleming I, Busse R: Intracellular pH and tyrosine phosphorylation but not calcium determine shear-stress-induccd nitric oxide production in native endothelial cells, Circ Res 1996:78:750-758.
21. Rees DD, Palmer RMJ, Schulz R, Moneada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br J Pharmacol 1990;101:746-751.
22. Rees DD, Palmer RMJ, Moneada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure, Proc Natl Acad Sci 1989:86:3375-3382.
23. Huang PL, Huang Z, Mashimo H, Block KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995:377: 239-242.
24. Moneada S, Vane VR: Pharmacology and endogenous roles of prostaglandin endoperox-ides, thromboxane A2 and prostacyclin, Pharmacol Rev 1979;30:293-331.
25. Parsaec H, Me Ewan JR., Sunil J, MacDermot J: Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells, Br J Pharmacol 1992;107:1013-1019.
26. White DG, Martin W: Differential control and calcium-dependent production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells, Br J Pharmacol 1989:97:683-690.
27. Jia L, Bonaventura C, Bonaventura J, Stander JS: S-nitrosohacmoglobin: A dynamic activity of blood involved in vascular control. Nature 1996;380:221-226.
28. Bath PMW, Hassell DG, Gladwin AM, Palmer RMJ, Martin JF: Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chcmotaxis and adhesion to endothelium in vitro, Artcrioscler Thromb 1991; 11:254-260.
29. Yates MT, Lambert LE, Whitten JP, Me Donald I, Mano M, Ku G, Mao JT: A protective role for nitric oxide in the oxidative modification of low-densitv lipoproteins by mouse macrophages, FEBS Lett 1992:309:135-138.
30. Hogg N, Kalvanaraman B, Joseph J, Struck A, Parthasarathy S: Inhibition of low density lipoprotein oxidation by nitric oxide: Potential role for athcrogcnesis, FEBS Lett 1993:334:170-174.
31. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J Clin Invest 1989;83:1774-1780.
32. Scott-Burdcn T, Vanhoutte PM: The endothelium as a regulator of vascular smooth muscle proliferation, Circulating 1993;87:V-51-V-55.
33. De Mey JG, Vanhoutte PM: Heterogeneous behavior of the canine arterial and venous wall, Importance of the endothelium, Circ Res 1982; 51:439-447.
34. Yanagisawa M, Kurihara H, Cintura S, Mitsui Y, Kobayashi M, Watanabe TX, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988:332: 411-418.
35. Liischer TF, Oemar BS, Boulanger CM, Hahn AW A: Molecular and cellular biology of endothelin and its receptors; in Lindpainter K, Ganten D (eds): Molecular Reviews in Cardiovascular Medicine, London, Chapman and Hall, 1996, pp 96-104.
36. Boulanger CM, Liischer TF: Release of endothelin from the porcine aorta, Inhibition of endothelium-derived nitric oxide, J Clin Invest 1990:85:587-590.
37. Yokokawa K, Kohno M, Yasunari C, Muraka-wa K, Takcda T: Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells, Hypertension 1991;18:304-315.
38. Stewart DJ, Langleben D, Cemacek P, Cian-flone K: Endothelin release is inhibited by coculture of endothelial cells with cells of vascular media. Am J Physiol 1990:259:H1928-H1932.
39. Vanhoutte PM, Boulanger CM: Endothelium-dependent responses in hypertension, Hyper-tens Res 1995;18:87-98.
40. Kalusic ZS, Vanhoutte PM: Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989:257:H33-H37.
41. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM: Generation of superoxide by purified brain nitric oxide synthase, J Biol Chcm 1992: 267:24173-24176.
42. 2+ calmodulin dependent formation of hydrogen peroxide by brain nitric oxide synthase, J Biol Chem 1992;281:627-630.
43. Flavahan NA, Vanhoutte PM: Endothelial cell signaling and endothelial dysfunction, Am J Hypertens 1995;8:28S-41S.
44. Berridgc MJ: Inositol trisphosphatc and calcium signalling. Nature 1993;361:315-325.
45. Fleming I, Fissltlialer B, Busse R: Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases, Circ Res 1995;76:522-529.
46. Bigay J, Dcterre P, Pfister C, Chabre M: Fluoride complexes of aluminium or beryllium act on G-protcins as rcversiblv bound analogues of the gamma-phosphate of GTP, EMBO J 1987; 6:2907-2913.
47. Shibano T, Codina J, Bimbaumer L, Van-houttc PM: Guanosinc 5'-0-(3-thiotriphos-phate) causes endothelium-dependent, pertussis toxin-sensitive relaxations in porcine coronary arteries, Biochem Biophys Res Comm 1992;189:324-329.
48. Flavahan NA, Vanhoutte PM: Pertussis toxin inhibits endothelium-dependent relaxations evoked by fluoride. Eur. JPharmacol 1990:178: 121-124.
49. Dolphin AC: Nucleotide binding proteins in signal transduction in health and disease, Trends Ncurosci 1987:10:53-57.
50. Flavahan NA, Shimokawa H, Vanhoutte PM: Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol 1989:408:549-560.
51. Shimokawa H, Flavahan NA, Vanhoutte PM: Natural course of the impairment of endothelium-dependent relaxations in regenerating porcine endothelial cells, Role of a pertussis toxin sensitive G-protein, Circ Res 1989:65: 740-753.
52. Schoeffter P, Hover D: 5-hydroxytryptaminc (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to 5-HTd receptor sub-type, J Pharm ExpTherap 1990:25:387-395.
53. Schini VB, Boulanger CM, Regoli D, Vanhoutte PM: Bradykinin stimulates the production of cyclic GMP via activation of B2 receptors in cultured endothelial cells, J Pharm Exp Ther 1990:252:581-585.
54. Nakaike R, Shimokawa H, Owada MK, Toku-naga O, Yasutakc H, Kishimoto T, Imada C, Shiraishi T, Egashira K, Takeshita A: Vanadate causes synthesis of endothelium-derived NO via pertussis toxin sensitive G protein in pigs. Am J Physiol 1996:271:H296-H302.
55. Shibano T, Codina J, Bimbaumer L, Vanhoutte PM: Pertussis toxin sensitive G-proteins in regenerated endothelial cells after balloon denudation of porcine coronary artery. Am J Physiol 1994;267:H979-H981.
56. Nagao T, Vanhoutte PM: Hyperpolarization as a mechanism for endothelium-dependent relaxations in porcine coronary arteries. J Physiol 1992;445:355-368.
57. Gil-Longo J, Dufour MN, Guillon G, Lugnier C: G proteins in aortic endothelial cells and bradykinin-induced formation of nitric oxide, Eur J Pharmacol 1993;247:119-125.
58. Liao JK, Homey CJ: The G-proteins of the Gai and Gaq family couple the bradykinin receptor to the release of endothelium-derived relaxing factor, J Clin Invest 1993;92:2168-2172.
59. Aoki H, Kobayashi S, Nishimura J, Kanaide H: Sensitivity of G protein involved in endothe-lin-1 induced Ca" influx to pertussis toxin in porcine endothelial cells in situ, Br J Pharmacol 1994:111:989-996.
60. Ladoux A, Frelin C: Endothelin inhibits adenylate cyclase in brain capillary endothelial cells, Biochem Biophys Res Comm 1991:180: 169-173.
61. Freeman JE, Kuo WY, Milligan G, Lowcnstein CJ, Levine MA, Flavahan NA: Analysis of pertussis toxin-sensitive receptor: G-protein interactions in native porcine endothelial cells, Endothelium 1995:3:321-330.
62. Day NS, Ge T, Codina J, Bimbaumer L, Vanhoutte PM; Boulanger CM: Gi proteins and the response to 5-hydroxytryptamine in porcine cultured endothelial cells with impaired release of EDRF, Br J Phamtacol 1995:115:822-827.
63. L.iao JK, Homey CJ: Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor, Circ Res 1992:70:1018-1026.
64. Voyno-Yasenetskaya TA, Pachenko MP, Nu-penko EV, Rybin VO, Tchachuk VA: Histamine and bradykinin stimulate the phosphoi-nositide turnover in human umbilical vein endothelial cells via different G-proteins, FEBS Lett 1989;259:67-70.
65. Asano T, Semba R, Kamviya N, Ogasawa N, Kato K: Ga GTP binding protein: Immunochemical and immunohistochcmical localization in the rat, J Neurochem 1988:50:1164-1169.
66. Liao JK, Homcv CJ: The release of endothelium-derived relaxing factor via a2-adrenergic receptor activation is specifically mediated by Gia2, J Biol Chem 1993;268:19528-19533.
67. Karnushina IL, Spatz M, Benbry J: Cerebral endothelial cell culture, I, The presence of beta-2 and alpha-2-adrcnergic receptors linked to adenylate cyclase, Life Sci 1982;30:849-858.
68. Ohno M, Gibbons GH, Dzau VJ, Cooke JP: Shear stress elevates endothelial cGMP: Role of a potassium channel and G protein coupling, Circulation 1993;88:193-197.
69. Vaca L, Schilling WP, Kunzc DL: G protein mediated regulation of a Ca"-dependent K* channel in cultured vascular endothelial cells, Pflügers Arch 1992:422:66-74.
70. Clapham DE, Neer EJ: New roles for G-protein by-dimers in transmembrane signalling. Nature 1993;365:403-406.
71. Taussig R, Iniguez-Lluhi JA, Gilman AG: Inhibition of adenylate cyclase by Gia, Science 1993:261:218-221.
72. Adams DJ, Rusko J, Van Slooten G: Calcium signalling in vascular endothelial cells; in Weir F.K (ed): Calcium entry and release in ion flux in pulmonary vascular endothelium, New York, Plenum Press, 1993, pp 259-275.
73. Park D, Jlton DY, Lee CW, Lee KH, Rhec SG: Activation of phospholipase C isozymes by G protein ßy subunits, J Biol Chem 1993;268: 4573-4576.
74. Watkins DC, Moxham CM, Morris AJ, Mal-bon CC: Suppression of Gia2 enhances phospholipase C signalling. Biochem J 1994:299: 593-596.
75. ras. Proc Natl Acad Sci USA 1994:91:12706-12710.
76. Touhara K, Hawes BE, Van Biesen T, Lefkowitz RJ: G protein ßy subunits stimulate phosphorylation of She adapter protein, Proc Nall Acad Sci USA 1995:92:9284-9287.
77. Tkachuk VA, Voyno-Yasenetskaya TA: Two types of G proteins involved in regulation of phosphoinositide turnover in pulmonary endothelial cells. Am J Physiol (Oct suppl) 1991: 261:118-122.
78. Boulanger CM, Vanhoutte PM: Cholera toxin augments the release of endothelium-derived relaxing factor evoked by bradykinin and the calcium ionophore A23187, Gen Pharmacol 1992;23:27-31.
79. 12P)ADP-ribosylation of proteins, Methods Enzymol 1991:195:369-382.
80. Klintz FJ, Costa T: Cholera toxin ADP ribosy-lates the receptor-coupled form of pertussis toxin sensitive G-proteins, Biochem Biophys Res Commun 1989:165:554-559.
81. Kuhn M, Otten A, Frölich JC, Förstcrman U: Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells, J Pharmacol Exp Ther 1991; 256:677-682.
82. Graicr WF, Groschenr K, Schmidt K, Kuko-vetz WR: Increases in endothelial cyclic AMP levelsamplify agonist-induced formation ofen-dothdium-derived relaxing factor (EDRF). Biochem J 1992;288:345-349.
83. Garcia JGN, Dominguez J, English D: Sodium floride incudes phosphoinositide hydroylysis, Ca" mobilization and prostacyclin synthesis in cultured human endothelium: Further evidence for regulation by a pertussis toxin insensitive guanine nucleotide binding protein, Am J Respir Cell Mol Biol 1991;5:113-124.
84. Bcrthiaume F, Frangos JA: Flow-induced prostacyclin production is mediated by a pertussis toxin-sensitive G-protcin, FEBS Lett 1992; 308:277-279.
85. Shimokawa H, Aarhus LL, Vanhoutte PM: Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin, Circ Res 1987;61:256-270.
86. Pearson PJ, Schaff HV, Vanhoutte PM: Longterm impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries, Circulation 1990:81:1921-1927.
87. Gohra H, Me Donald TO, Verrier ED, Aziz S: Endo’.helial loss and regeneration in a model of transplant arteriosclerosis, Transplantation 1995;60:96-102.
88. Shimokawa H, Flavahan NA, Shepard JT, Vanhoutte PM: Endothelium-dependent inhibition of ergonovine-induced contraction is impaired in porcine coronary arteries with regenerated endothelium, Circulation 1989:80:643-650.
89. Shimokawa H, Vanhoutte PM: Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis, Circ Res 1989:64: 900-914.
90. Borg-Capra C, Fournet-Bourguignon MP, Ja-niak P, Villeneuve N, Bidouard JP, Vilaine JP, Vanhoutte PM: Morphological heterogeneity with normal expression but altered function of Gi proteins in cultured regenerated porcine coronary endothelial cells (abstract 3471), Fa-seb 1996; I0:A602.
91. Flavahan NA: Lysophosphatidylcholinc modifies G-proteins dependent signaling in porcine endothelial cells. Am J Physiol 1993,264: H722-H727.
92. Liao J K, Clark SL: Régulât ion of G-protcin a2 i subunit expression by oxidized low-density lipoprotein, J Clin Invest 1995;95:1457-1463.
93. Tsutsui M, Shimokawa H, Tanaka S, Kuwoaka I, Hase K, Nogami N, Nakanishi K, Okamatsu S: Endothelial Gi protein in human coronary arteries, Eur Heart J 1994;15:1261-1266.
94. Shimokawa H, Tsutsui M, Mizuki T, Hase K., Kuwaoka I, Nogami N, Okamatsu S, Nakanishi K: Endothelial Gi protein expression is markedly low in human coronary microvessels, J Cardiovasc Pharmacol 1996:27:297-302.
95. Richard V, Tanner FC, Tschudi M, Liischer TF: Different activation of Jarginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol 1990;259:H1433-H1440.
96. Tschudi M, Richard V, Biihler FR, Liischer TF: Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 1991;260:H13-H21.
97. Tanner FC, Noll G, Boulanger CM, Liischer TF: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries, Role of scavenger receptor and endothelium-derived nitric oxide, Circulation 1991;83:2012-2121.
98. Liao JK, Shin WS, Lee WY, Clark SL: Oxidized low-density lipoproteins decrease the expression of endothelial nitric oxide synthase, J Biol Chem 1995;270:319-324.
99. Boulanger CM, Tanner FC, Bea M-L, Werner A, Hahn AW A, Liischer TF: Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium, Circ Res 1992;70: 1191-1197.
100. Lerman A, Edwards BS, Halletl JW, Heub-Icin DM, Sandberg SM, Bumett JC Jr.: Circulating and tissue endothelin immunoreactivi-ty in advanced atherosclerosis, N Engl J Med 1991:325:997-999.
101. Vanhoutte PM, Boulanger CM, Mombouli JV: Endothelium-derived relaxing factors and converting enzyme inhibition, Am J Cardiol 1995;76:3E-12E.